Welcome to LookChem.com Sign In|Join Free
  • or
3-Pyridinecarboxylic acid, 1-acetyl-1,4-dihydro-4-phenyl-, ethyl ester is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

350032-39-2

Post Buying Request

350032-39-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

350032-39-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 350032-39-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,5,0,0,3 and 2 respectively; the second part has 2 digits, 3 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 350032-39:
(8*3)+(7*5)+(6*0)+(5*0)+(4*3)+(3*2)+(2*3)+(1*9)=92
92 % 10 = 2
So 350032-39-2 is a valid CAS Registry Number.

350032-39-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name ethyl 1-acetyl-1,4-dihydro-4-phenylpyridine-3-carboxylate

1.2 Other means of identification

Product number -
Other names ethyl 1-acetyl-4-phenyl-1,4-dihydropyridine-3-carboxylate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:350032-39-2 SDS

350032-39-2Relevant academic research and scientific papers

Evaluation of novel substituted furopyridines as inhibitors of protein kinases related to tau pathology in alzheimer′s disease

Ansideri, F.,Hilgeroth, A.,Holzer, M.,Koch, P.,Krystof, V.,Schade, N.

, p. 844 - 855 (2021/10/20)

Background: Alzheimer′s disease (AD) is characterized by a progressive neuronal degeneration caused by two pathological hallmarks, hyperphosphorylated tau protein aggregated into tau filaments and amyloid precursor protein derived beta amyloid peptides aggregated into extracellular amyloid plaques. All attempts so far to find effective drugs failed in clinical trials. AD is a multifactorial disease, so that selective drugs to target one AD-relevant structure alone may not be sufficient. Objective: We built novel furopyridines with various substitution patterns to evaluate them as protein kinases inhibitors of enzymes related to tau pathology. Methods: Furopyridine derivatives were synthesized and purified using column chromatography. The protein kinase inhibitory properties were determined in ATP-competition assays with determined affinity constants for the most active compounds. Results: The compounds were prepared in simple two-component reactions of substituted 1,4-dihydropyridines and respective quinones to obtain various substitutions of the molecular furopyridine scaffold. The substituent effects on the determined kinase inhibitory properties of cdk1, cdk2, Fyn, JNK3 and gsk-3β are discussed. Conclusion: Various 3-substitutions were found most sensitive for the protein kinase inhibition de-pending on the length, nature and a substituent positioning within. We identified compounds as inhibitors of several kinases as a tool to potentially combat the disease progress in a multitargeting approach.

Synthesis and first biological evaluation of 1-aza-9-oxafluorenes as novel lead structures for the development of small-sized cytostatics

Brachwitz, Kristin,Hilgeroth, Andreas

, p. 411 - 413 (2007/10/03)

A first series of novel 1-aza-9-oxafluorenes has been prepared from 3-carbonyl substituted 1,4-dihydropyridines and p-benzoquinone as small-sized cytostatics. Biological evaluation has been carried out in various cancer cell-lines. First structure-activity relationships proved the 4-phenyl substituent to be more favorable than the 4-methyl substituent. Cytostatic properties are discussed.

Regioselective formation of novel functionalized 1-aza-9-oxafluorenes

Hilgeroth, Andreas,Brachwitz, Kristin,Baumeister, Ute

, p. 661 - 669 (2007/10/03)

A small series of novel 1-aza-9-oxafluorenes have been prepared by regioselective cycloaddition reaction of p-benzoquinone to the sterically unhindered side of unsymmetrically substituted N-acyl-1,4-dihydropyridines (1). The stereochemistry of the product

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 350032-39-2